Selective KIT-inhibition Supports Mast Cells as Key Drivers of Allergic Asthma Pathogenesis

Study limitation reported by the research below: “All efficacy findings are from in vitro (human cells/tissue) and guinea pig in vivo experiments — no human clinical trial data exist yet for THB001.”